Epidemiology of Drug Abuse (R21)

Post Date

June 16th 2011

Application Due Date

September 7th 2014

Funding Opportunity Number

PA-11-231

CFDA Number(s)

93.279

Funding Instrument Type(s)

Grant

Funding Activity Categories

Education
Health

Eligibility Categories

State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Funding

• Award Range:

  $None - $200000

Grant Description

This Funding Opportunity Announcement (FOA) issued by the National Institute on Drug Abuse (NIDA), is intended to support research projects with the R21 mechanism to enhance our understanding of the nature, extent, distribution, etiology, and consequences of drug use, abuse, and addiction across individuals, families, communities, and diverse population groups. This Program strongly encourages applications that address multiple levels of causation, reflecting the breadth of epidemiology research, that are transdisciplinary in nature and apply novel methods that allow for the advancement of science (e.g., those that investigate interplay among genetic, environmental, and developmental factors, or those that examine how aspects of social environments affect health outcomes), as well as those that take advantage of the investments made by NIH and other funders by using existing data to inform our understanding of drug abuse epidemiology and etiology in a creative and cost efficient manner.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/pa-files/PA-11-231.html